XML 47 R33.htm IDEA: XBRL DOCUMENT v3.19.1
10. Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2018
Share-based Compensation [Abstract]  
Schedule of options granted under employee stock plans
    Shares Available for Grant     Number of Shares Outstanding     Weighted-Average Exercise Price  
                   
Balance as of December 31, 2016     98       1,632     $ 4.37  
Authorized     655       -       -  
Granted     (899 )     899       1.41  
Forfeited/expired     342       (342 )     7.32  
Balance as of December 31, 2017     196       2,189     $ 2.70  
Authorized     655       -       -  
Granted     (1,148 )     1,148       1.07  
Exercised     -       (2 )     0.67  
Forfeited/expired     446       (446 )     4.35  
Balance as of December 31, 2018     149       2,889     $ 1.80  
Schedule of weighted average fair value calculations for options
    Number of Shares       Weighted Average Exercise Price     Remaining Contractual Term (In Years)     Average Intrinsic Value1  
2018                        
Vested and Exercisable     1,923     $ 2.01       7.34     $ -  
Unvested     966       1.38       8.81       -  
Total     2,889     $ 1.80       7.80     $ -  
                                 
2017                                
Vested and Exercisable     1,515     $ 2.94       5.83     $ -  
Unvested     674       2.16       8.62       -  
Total     2,189     $ 2.70       6.68     $ -  

 

———————

(1) Intrinsic value based on the $0.61 and $0.55 closing price of Aemetis stock on December 31, 2018 and 2017 respectively, as reported on the NASDAQ Exchange.

 

Schedule of assumptions for weighted-average fair value calculations for options granted
Description   For the year ended December 31,  
    2018     2017  
Dividend-yield     0 %     0 %
Risk-free interest rate     2.71 %     2.22 %
Expected volatility     82.99 %     76.96 %
Expected life (years)     6.48       6.42  
Market value per share on grant date   $ 1.07     $ 1.41  
Fair value per share on grant date   $ 0.79     $ 0.99  
Schedule of assumptions for remeasurement of SARs
Description   At December 31, 2018  
       
Risk-free interest rate     2.60 %
Expected volatility     125
Market value per share on grant date   $ 0.61  
Fair value per share on grant date   $ 1.08  
Fair value of warrant liability
    Total     Level 1     Level 2     Level 3  
2018                        
SARs liability   $ 1,132     $ -     $ -     $ 1,132  
Activity of level 3 liabilities
    SARs Liability Balance  
Balance on August 23, 2018   $ 1,277  
Related change in fair value     (145 )
Balance as of December 31, 2018   $ 1,132